Multiplex Assay Kit for GA Binding Protein Transcription Factor Alpha (GABPa) ,etc. by FLIA (Flow Luminescence Immunoassay)

E4TF1-60; E4TF1A; NFT2; NRF2; NRF2A; Nuclear Respiratory Factor-2 Subunit Alpha; Transcription factor E4TF1-60

(Note: Up to 8-plex in one testing reaction)

Specificity

This assay has high sensitivity and excellent specificity for detection of GA Binding Protein Transcription Factor Alpha (GABPa) ,etc. by FLIA (Flow Luminescence Immunoassay).
No significant cross-reactivity or interference between GA Binding Protein Transcription Factor Alpha (GABPa) ,etc. by FLIA (Flow Luminescence Immunoassay) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of recombinant GA Binding Protein Transcription Factor Alpha (GABPa) ,etc. by FLIA (Flow Luminescence Immunoassay) and the recovery rates were calculated by comparing the measured value to the expected amount of GA Binding Protein Transcription Factor Alpha (GABPa) ,etc. by FLIA (Flow Luminescence Immunoassay) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 82-89 86
EDTA plasma(n=5) 91-99 95
heparin plasma(n=5) 80-101 89
sodium citrate plasma(n=5) 92-101 96

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level GA Binding Protein Transcription Factor Alpha (GABPa) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level GA Binding Protein Transcription Factor Alpha (GABPa) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of GA Binding Protein Transcription Factor Alpha (GABPa) ,etc. by FLIA (Flow Luminescence Immunoassay) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 88-96% 79-93% 81-101% 80-96%
EDTA plasma(n=5) 98-105% 88-101% 78-104% 82-99%
heparin plasma(n=5) 99-105% 96-103% 81-89% 83-92%
sodium citrate plasma(n=5) 94-101% 85-96% 95-103% 80-97%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity
96-well plate 1 Plate sealer for 96 wells 4
Pre-Mixed Standard 2 Standard Diluent 1×20mL
Pre-Mixed Magnetic beads (22#:GABPa) 1 Analysis buffer 1×20mL
Pre-Mixed Detection Reagent A 1×120μL Assay Diluent A 1×12mL
Detection Reagent B (PE-SA) 1×120μL Assay Diluent B 1×12mL
Sheath Fluid 1×10mL Wash Buffer (30 × concentrate) 1×20mL
Instruction manual 1

Assay procedure summary

1. Preparation of standards, reagents and samples before the experiment;
2. Add 100μL standard or sample to each well,
    add 10μL magnetic beads, and incubate 90min at 37°C on shaker;
3. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent A. Incubate 60min at 37°C on shaker;
4. Wash plate on magnetic frame for three times;
5. Add 100μL prepared Detection Reagent B, and incubate 30 min at 37°C on shaker;
6. Wash plate on magnetic frame for three times;
7. Add 100μL sheath solution, swirl for 2 minutes, read on the machine.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
Life Sciences Crocin attenuates lung inflammation and pulmonary vascular dysfunction in a rat model of bleomycin-induced pulmonary fibrosis Pubmed: 31465731
Life Sci The protective effect of Lactobacillus versus 5-aminosalicylic acid in ulcerative colitis model by modulation of gut microbiota and Nrf2/Ho-1 pathway Pubmed: 32526285
Vet Sci Protective and Therapeutic Effects of Orlistat on Metabolic Syndrome and Oxidative Stress in High-Fat Diet-Induced Metabolic Dysfunction-Associated Fatty Liver … 34822647
Antioxidants (Basel) Hepatoprotective Effect of Bee Bread in Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) Rats: Impact on Oxidative Stress and Inflammation 34943134
Catalog No. Related products for research use of Homo sapiens (Human) Organism species Applications (RESEARCH USE ONLY!)
RPG693Hu01 Recombinant GA Binding Protein Transcription Factor Alpha (GABPa) Positive Control; Immunogen; SDS-PAGE; WB.
PAG693Hu01 Polyclonal Antibody to GA Binding Protein Transcription Factor Alpha (GABPa) WB; IHC; ICC; IP.
MAG693Hu21 Monoclonal Antibody to GA Binding Protein Transcription Factor Alpha (GABPa) WB; IHC; ICC; IP.
SEG693Hu ELISA Kit for GA Binding Protein Transcription Factor Alpha (GABPa) Enzyme-linked immunosorbent assay for Antigen Detection.
LMG693Hu Multiplex Assay Kit for GA Binding Protein Transcription Factor Alpha (GABPa) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.